| Filed On | Filing |
|---|---|
| 25 Sep 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Other Events
SAN DIEGO, September 25, 2026 – Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced that on September 21, 2026,... |
| 22 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Stock Purchase Agreement (this “Agreement”) is dated as of September 17, 2026, between Calidi Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, includin... |
| 17 Sep 2026 | 424B5 |
| 19 Aug 2026 |
Form 4: Peoples George, Director
Granted 4,000 Non-Qualified Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Leftwich Scott, Director
Granted 4,000 Non-Qualified Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Stewart Alan R., Director
Granted 4,000 Non-Qualified Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Jackson Andrew C., Chief Financial Officer
Granted 14,000 Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Schoeneck James A, Director
Granted 5,000 Non-Qualified Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Poma Eric E, Chief Executive Officer
Granted 32,000 Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Fernandez Santidrian Antonio, Chief Scientific Officer
Granted 16,000 Stock Options (right to buy) |
| 19 Aug 2026 |
Form 4: Sanders Corazon (Corsee) D., Director
Granted 6,000 Non-Qualified Stock Options (right to buy) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 31 Jul 2026 | 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year |
| 16 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more |
| 29 Jun 2026 |
Form 3: Sanders Corazon (Corsee) D., Director
No securities owned |
| 23 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more |
| 18 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 05 Jun 2026 | DEFA14A |
Loading...
